NHD Global
Healing & Tissue Repair · Source-reviewed dossier
Source-Reviewed Research Dossier
KPV is a short three-amino-acid peptide, named for lysine, proline and valine. Research has examined inflammatory signaling in cells and experimental intestinal inflammation in animals. Some studies deliver KPV using a carrier, such as nanoparticles or a hydrogel; that carrier is part of the experiment. This page explains the findings in plain language, separates free-peptide and delivery-system results, and lists the identity and variants relevant to a research quotation.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A 2025 study reported reduced apoptosis and inflammatory signaling in a fine-dust-exposed keratinocyte model.
In-vitro exposure cannot establish topical or systemic human outcomes.
Read the primary studyKPV-loaded nanoparticles in a polysaccharide hydrogel were evaluated in a mouse colitis model.
The delivery system and animal model are integral to the result.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
In-vitro exposure cannot establish topical or systemic human outcomes.
View primary recordThe delivery system and animal model are integral to the result.
View primary recordThird-party publications selected for direct relevance.
Cell study. 2025. PMID 40073467.
Laroui H, et al. Gastroenterology. 2010. PMID 19909746.
Concise answers for researchers comparing identity, evidence and catalog variants.
In human skin cells exposed to fine dust, KPV reduced oxidative stress, lowered IL-1 beta, and limited cell-death signals. In a mouse colitis model, KPV delivered in nanoparticles and a gel reduced gut damage. These are lab and animal findings only. They do not prove KPV treats skin damage, colitis, or any condition in people.
The findings listed here come from cells or mice. The linked studies do not establish controlled human treatment benefits. Catalog KPV is for research use only. Its identity and purity are set by the product specification and lot documents, not by biological results. A vial is not a medicine and has no proven health benefit.
The available evidence includes cell work and targeted-delivery animal studies rather than controlled human trials.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
Tell us which records your project requires. Availability and scope must be confirmed for the selected material. Published papers are not batch certificates, and this page does not confirm that a lot-specific COA is available.
Request the storage conditions for the exact supplied form and selected variant. A temperature stated for another supplier or a clinical drug preparation is not a verified storage specification for NHD catalog material.
Not necessarily. The study design must say which groups were compared. A carrier can affect where and how much material reaches the tested tissue, so the combination should not be treated as equivalent to an unformulated research vial.
Send the exact product name, selected catalog variant, required quantity, destination and documents needed for the project. Specify whether the amount refers to powder mass or measured peptide content. Availability, price, lead time and document scope require confirmation.
No. A paper describes the material and methods used in that study. It does not establish the identity, purity or content of a different supplied lot. Ask which records actually apply to the requested material; do not assume a COA is available.
Knowledge center
Owned educational content connected to this family.
KPV research spans keratinocyte stress models and targeted colon-delivery systems. The published effects are preclinical, and FDA states that it has not identified human…
Updated October 1, 2026
KPV is a short peptide made from three amino acids. Its name is an abbreviation: K means lysine, P means proline and V means…
Updated October 3, 2026
A headline about a much lower peptide concentration can sound like proof that the peptide itself became stronger. In a KPV study, however, the…
Updated October 5, 2026
KPV is a three-amino-acid peptide. Researchers examined whether a transport pathway called PepT1 helped it enter cells and affect inflammatory signaling. This guide explains…
Updated October 9, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: KPV5 · 5 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
